Gabriel Jones, CEO and co-founder of Proprio, a medical tech company, innovates in surgery using AI and machine learning. With over a decade of leadership in emerging technology and intellectual property law, he specializes in AI, machine learning, and healthcare, driven by a passion to help others and bring new ideas to life.<\/p>\n\n\n\n
Q1. Please provide us a brief bio of yourself.<\/strong><\/p>\n\n\n\n I am Gabriel Jones, the CEO and co-founder of Proprio, a medical technology company taking a unique approach to leveraging AI and machine learning in surgery.<\/p>\n\n\n\n I am an experienced technology leader with a passion for helping others and bringing innovations to life. I have more than a decade of leadership experience in emerging technology and intellectual property law, with specific expertise in AI, machine learning, and healthcare. I began my career in international trade in Japan and Washington, DC, and also worked on large-scale mergers and acquisitions on Wall Street.<\/p>\n\n\n\n Prior to co-founding Proprio, I worked with the Bill & Melinda Gates Foundation on global initiatives in health and technology, also helping Gates and the Microsoft leadership team with new technology development and evaluation. My passion for creating direct social impacts led me to new technology ventures where I helped commercialize several successful startups, ranging from biotech and med tech to AI and property technologies.<\/p>\n\n\n\n Q2. What inspired you to pursue innovation in your field?<\/strong><\/p>\n\n\n\n Throughout my career working in technology, I know that the potential for healthcare lies in healthcare revolution. I have seen firsthand the amount of data collection that is lost every day because of the lack of technology to capture it. Every surgeon\u2019s method, workflow, and outcome are lost to a black box of wasted potential in the operating room.<\/p>\n\n\n\n Amidst the increasing adoption of AI in post-operative and diagnostic domains, only a handful have ventured into the realm of AI\u2019s potential to be utilized intraoperatively. Seeing this as an opportunity to revolutionize how AI is used in surgery, I co-founded Proprio with the goal of creating an intraoperative system that harnesses the power of AI and advanced imaging to give surgeons a greater depth of anatomical information while exponentially increasing surgical accuracy and efficiency. I saw that surgery has the potential to operate more efficiently with a roadmap to success similar to how MapQuest was revolutionary to anyone who drove a car, and that is what inspired me the most.<\/p>\n\n\n\n Q3. Please tell us more about your organization.<\/strong><\/p>\n\n\n\n Proprio is a medical technology company creating a new way of seeing in spinal surgery. Using advancements in light field, AI, and other emerging technologies, our flagship product, the Paradigm system, will be used to reach our goal of dramatically improving clinical and economic outcomes in healthcare. This technology enables the capture of advanced data and harnesses the potential of this data to enhance predictive and prescriptive intelligence in surgery, aiming to make surgery more efficient and accurate.<\/p>\n\n\n\n The Paradigm system is the first surgical navigation system to use light field technology in spine surgery for this use case. By capturing high-definition intraoperative images and fusing that data with preoperative scans, surgeons are able to \u201csee\u201d the surgical field in a completely new way. Using this technology, surgeons will no longer need to rely on a mix of time-consuming legacy tools (like CT or X-ray scans), that all pull attention away from the patient and reduce accuracy in the process.<\/p>\n\n\n\n Q4. What does \u201cInnovation\u201d mean to you?<\/strong><\/p>\n\n\n\n I believe that being innovative means pursuing groundbreaking solutions that enhance surgical outcomes, streamline processes and ultimately improve patient care. It involves fostering a culture of curiosity, for example, I encourage my team to think beyond conventional boundaries and challenge the limits of technology. Innovation is not just about developing cutting-edge technologies but also about understanding the complex landscape of healthcare and addressing the needs of patients and medical professionals equally.<\/p>\n\n\n\n It’s a commitment to continuously stay ahead of the curve, anticipate societal needs, and collaborate with the medical community to ensure Paradigm remains at the forefront of progress. I see innovation as a strategic imperative, a constant pursuit of excellence that aligns with our vision to redefine the future of surgery.<\/p>\n\n\n\n Q5. Can you briefly describe your innovation and its impact?<\/strong><\/p>\n\n\n\n It\u2019s commonly known across the spinal technology industry that spinal implants have become commoditized, and companies can no longer differentiate based on implants alone. Even though the global spinal implant and surgical device market is set to be worth $14.1 billion by 2028, innovation in implant technology has been stagnant in recent years. While it was once a rapidly expanding area of the industry, product differentiation has stalled.<\/p>\n\n\n\n Our Paradigm system breaks through the crowded medical technology industry by synthesizing data across multiple sensors, creating a real-time, interactive 3D canvas of human anatomy during spine surgery. Paradigm synthesizes views from multiple sensors and cameras, allowing surgeons to navigate anatomical and surgical environments by creating an interactive 3D canvas of human anatomy. As the patient is undergoing spinal surgery, surgeons can see spinal implant placements in real-time, throughout the procedure, without the need for repeated CT scans.<\/p>\n\n\n\n <\/p>\n\n\n\n <\/p>\n\n\n\n Proprio\u2019s flagship product, Paradigm, is the first spine surgical navigation platform to utilize light field imaging technology fused with AI to help surgeons \u2026 (Read more at TITAN Innovation Awards<\/a>).<\/p>\n\n\n\n